Arun Indu, Roy Paromita, Arora Neeraj, Bhave Saurabh Jayant, Nair Reena, Chandy Mammen
1 Tata Medical Center, Kolkata, West Bengal, India.
Int J Surg Pathol. 2017 Jun;25(4):333-338. doi: 10.1177/1066896916683447. Epub 2016 Dec 26.
Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL) is a subtype of T-cell lymphomas that may mimic several other malignancies morphologically. With the help of immunohistochemistry, most cases of ALCL can be diagnosed on the basis of expression of T-cell lineage associated antigens. However, aberrations in the expression of immunohistochemical markers pose diagnostic challenges. The morphological and immunophenotypic features of ALCL show considerable overlap with classical Hodgkin lymphoma (CHL), which is a B-cell lymphoma. The 2008 World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues suggests that staining for the B-cell transcription factor, paired box 5 (PAX-5), is helpful in differentiating between them, as it is weakly positive in most CHL and should be negative in ALCL. We report a rare case of ALK-negative ALCL, which was positive for PAX-5 and CD15, mimicking CHL by immunohistochemistry, resulting in a diagnostic dilemma.
间变性淋巴瘤激酶(ALK)阴性间变性大细胞淋巴瘤(ALCL)是T细胞淋巴瘤的一种亚型,在形态学上可能与其他几种恶性肿瘤相似。借助免疫组织化学,大多数ALCL病例可根据T细胞谱系相关抗原的表达进行诊断。然而,免疫组织化学标志物表达的异常带来了诊断挑战。ALCL的形态学和免疫表型特征与经典霍奇金淋巴瘤(CHL,一种B细胞淋巴瘤)有相当大的重叠。2008年世界卫生组织造血与淋巴组织肿瘤分类表明,B细胞转录因子配对盒5(PAX-5)染色有助于区分两者,因为它在大多数CHL中呈弱阳性,而在ALCL中应为阴性。我们报告了1例罕见的ALK阴性ALCL病例,该病例PAX-5和CD15呈阳性,免疫组织化学表现类似CHL,导致诊断困境。